|
|
 | | | | | | | Italy
Indication: Indicated for the treatment of acute mania.
Brand name: Zyprexa.
Regulatory status: Registered in October 2003 in the EU for the prevention of recurrence of bipolar disorder. Expected to receive add-on for the indication of maintenance of mood stabilization.
Launch date: Not available.
| | | |
|
